Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
Tomohiro KogaShuntaro SatoJunya MiyamotoNaoko HagimoriYurika KawazoeKumiko ArinagaChizu FukushimaHiroshi YamamotoAtsushi KawakamiPublished in: Trials (2018)
University Hospital Medical Information Network Clinical Trials Registry, UMIN000028010 . Registered on 7 July 2017.